Parkwalk Advisors has co-led a £6.3 million Series A funding round in MoA Technology, a University of Oxford spin-out focused on developing sustainable herbicides using innovative discovery platforms.
Information on the Target
MoA Technology is a pioneering company that has emerged as a spin-out from the University of Oxford, specifically from the Plant Sciences Department. Founded in 2018 by renowned researchers Professor Liam Dolan FRS and Dr. Clement Champion, the company focuses on developing innovative solutions for crop protection. Its primary aim is to design sustainable herbicides utilizing new modes of action derived from both natural and synthetic chemical compounds.
To date, MoA Technology has successfully developed three proprietary platforms - MoA Galaxy, MoA Target, and MoA Select. Each platform possesses distinct capabilities; however, when integrated, they present an unprecedented opportunity to transform the herbicide discovery landscape. These platforms leverage a sophisticated interplay of genetic analysis, trait evaluation, and data analytics to identify and create new, efficient, and environmentally-friendly herbicides.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The agricultural sector in the United Kingdom is one of the most advanced in the world, characterized by its commitment to sustainable practices and innovation. The demand for effective crop protection solutions in the UK has grown signific
Similar Deals
Parkwalk
invested in
MoA Technology
in 2023
in a Series A deal
Disclosed details
Transaction Size: $8M